1. Home
  2. CTMX vs MNY Comparison

CTMX vs MNY Comparison

Compare CTMX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • MNY
  • Stock Information
  • Founded
  • CTMX 2008
  • MNY 2014
  • Country
  • CTMX United States
  • MNY Singapore
  • Employees
  • CTMX N/A
  • MNY 366
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • CTMX Health Care
  • MNY
  • Exchange
  • CTMX Nasdaq
  • MNY Nasdaq
  • Market Cap
  • CTMX 89.1M
  • MNY 43.8M
  • IPO Year
  • CTMX 2015
  • MNY N/A
  • Fundamental
  • Price
  • CTMX $1.16
  • MNY $1.09
  • Analyst Decision
  • CTMX Buy
  • MNY
  • Analyst Count
  • CTMX 6
  • MNY 0
  • Target Price
  • CTMX $5.77
  • MNY N/A
  • AVG Volume (30 Days)
  • CTMX 694.5K
  • MNY 96.3K
  • Earning Date
  • CTMX 11-05-2024
  • MNY 12-04-2024
  • Dividend Yield
  • CTMX N/A
  • MNY N/A
  • EPS Growth
  • CTMX N/A
  • MNY N/A
  • EPS
  • CTMX 0.13
  • MNY N/A
  • Revenue
  • CTMX $119,569,000.00
  • MNY $88,967,081.00
  • Revenue This Year
  • CTMX $1.96
  • MNY $35.91
  • Revenue Next Year
  • CTMX N/A
  • MNY $23.67
  • P/E Ratio
  • CTMX $8.62
  • MNY N/A
  • Revenue Growth
  • CTMX 50.41
  • MNY 28.08
  • 52 Week Low
  • CTMX $1.04
  • MNY $0.74
  • 52 Week High
  • CTMX $5.85
  • MNY $4.70
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 48.86
  • MNY 46.60
  • Support Level
  • CTMX $1.12
  • MNY $1.02
  • Resistance Level
  • CTMX $1.19
  • MNY $1.25
  • Average True Range (ATR)
  • CTMX 0.05
  • MNY 0.07
  • MACD
  • CTMX 0.00
  • MNY 0.01
  • Stochastic Oscillator
  • CTMX 50.00
  • MNY 37.74

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.

Share on Social Networks: